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Previewsand how important it is to take this
into account when planning vaccine or
intervention strategies. Several intriguing
questions remain regarding pneumo-
coccal carriage, transmission, and evolu-
tionary adaptation. Are carriage strains of
S. pneumoniae in SCD patients continu-
ously reseeded from strains carried by
the GP, or are these transmitted from
SCD patient to patient? If the latter is
true, this would mean that the pneumo-
coccus is undergoing parallel but sepa-
rate linear evolutionary pathways in thesetwo populations. The use of ‘‘designer’’
vaccines to target these populations
should be considered.REFERENCES
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The NOD-like receptors (NLRs) were among the first innate immune receptors discovered, yet a clear
understanding of the basic principles underlying their mechanisms of action is lacking. Two recent studies
provide important cell biological insights into the subcellular sites of NOD1- and NOD2-dependent signaling.The modern field of innate immunity is
centered on the study of several families
of pattern recognition receptors (PRRs).
These receptor families include the Toll-
like receptors (TLRs), NOD-like receptors
(NLRs), C-type lectin receptors (CLRs),
RIG-I-like receptors (RLRs), and AIM2-
like receptors (ALRs). Each of these
receptor families functions to detect mi-
crobial products in a multicellular host
and induces one or more antimicrobial re-
sponses that prevent infection. As such,
muchwork in this area has focused on un-
derstanding how PRRs detect microbial
products and the mechanisms of subse-
quent signal transduction. Despite being
one of the first PRR families discovered
(Philpott et al., 2014), insight into the
means by which NLRs detect their micro-
bial products lags far behind the other
families. Two recent studies have ad-
dressed these deficiencies in our knowl-
edge (Irving et al., 2014; Nakamura et al.,
2014), providing us with a much clearer
understanding of the earliest events asso-ciated with the activation of NLR-depen-
dent innate immune responses.
NLRs are a structurally related family of
proteins, with individual family members
serving distinct biological functions (Phil-
pott et al., 2014). For example, some
NLRs act as transcription factors in the
nucleus to promote the expression of
major histocompatibility complex (MHC)
genes, andothersact ascentral regulators
of inflammasome activation (Davis et al.,
2011). The assignment of NLRs as PRRs
came from studies of the NOD1 and
NOD2 proteins, which were found to acti-
vate NF-kB-dependent cytokine expres-
sion during infections with bacteria that
enter the cytosol. Reductionist studies
subsequently revealed that NOD1 and
NOD2 can be activated by specific com-
ponents of the bacterial cell wall, such
as d-glutamyl-meso-diaminopimelic acid
(iE-DAP) in the case ofNOD1 andmuramyl
dipeptide (MDP) in the case of NOD2 (Phil-
pott et al., 2014). Despite this knowledge,
several confusing aspects of NOD1 andNOD2 biology remained. For example, it
has been difficult to detect direct interac-
tions between these receptors and their
proposed ligands, whereas similar in-
quiries into receptor-ligand interactions
with other PRR families have been suc-
cessful. This issue has been further
complicated by the recent discovery that
some NLR family members do not bind
to microbial products directly, but rather
interact with upstream proteins of the
NAIP family that bind to specific microbial
ligands (Kofoed and Vance, 2011). These
findings raised the possibility that at least
some NLR family members are not actu-
ally PRRs, but are adaptor proteins that
facilitate the signaling functions of up-
stream PRRs. A second confusing aspect
of NLR biology has emerged from studies
demonstrating that natural NOD ligands
can trigger NF-kB activation when added
to the extracellular media of cultured cells
(Kaparakis et al., 2010). This finding was
surprising, since the NODs are cytosolic
proteins. Thus, it has long been suspected15, May 14, 2014 ª2014 Elsevier Inc. 523
Figure 1. Proposed Model to Explain the Initiation of NOD1- and
NOD2-Dependent Signal Transduction
Host mammalian cells can internalize the bacteria they encounter by phagocy-
tosis. NOD proteins may be recruited to sites of phagocytosis by an unknown
mechanism. The NODs then remain attached to the formed phagosome and
will detect microbial cell wall components after they are released in the degra-
dative endosomal network. The peptide transporter SLC15A3 likely functions
to transport NOD ligands across endosomal membranes to the receptor(s),
which then initiates innate immune signal transduction.
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endolysosomal network of
mammalian cells facilitates
the delivery of NOD ligands
to cytosolic receptors. The
nature of this proposed trans-
porter has remained elusive,




by Mellman and colleagues
and Kaparakis-Liaskos and
colleagues have addressed
these deficiencies in our
knowledge (Irving et al.,
2014; Nakamura et al., 2014)
and in the process identified
endosomal membranes as
sites of NOD1/NOD2-depen-
dent signal transduction. The
study by Mellman sought to
address the means by which
the NOD2 ligand MDP is
released from endosomes in
dendritic cells (DCs). Using a
proteomic approach to query
phagosomes, the authorssearched for transporters that may
mediate the movement of small peptides
across membranes. SLC15A3 and the
related protein SLC15A4 were the most
promising candidates. The authors found
these proteins to be highly enriched on
endosomal membranes, and prior work
demonstrated their ability to transport
peptides across membranes using the
proton gradient as an energy source
(Daniel and Kottra, 2004; Lee et al.,
2009). This latter point was interesting,
as MDP-induced NF-kB activation is sen-
sitive to chemicals that disrupt the acidic
nature of endosomes (Lee et al., 2009).
Several elegant experiments implicated
SLC15A3 in the transport of MDP and
the activation of NOD2. For example,
DCs lacking SLC15A3 exhibited substan-
tial defects in cytokine expression
induced by MDP-coated beads or bacte-
ria, whereas cellular responses to LPS
were unaffected. In addition, studies in
293T epithelial cells ruled out a role for
these transporters in the innate immune
responses to flagellin and TNF. Perhaps
most convincingly, the authors cleverly
engineered a mutant of SLC15A3 that is
localized to the plasma membrane, rather
than endosomes. As compared to cells
expressing endosomal SLC15A3, cells524 Cell Host & Microbe 15, May 14, 2014 ª2expressing plasma membrane-localized
SLC15A3 exhibited an enhanced ability
to deliver extracellular MDP to the cytosol
and an enhanced ability to induce cyto-
kine expression. The enhancement of sig-
naling likely results from a bypass of the
endocytosis bottleneck that usually limits
the amount of MDP that can be delivered
to endosomes containing this transporter.
Thus, using both loss- and gain-of-func-
tion approaches, Mellman and colleagues
convincingly implicate SLC15A3 in the
transport of MDP to NOD2. These data,
coupled with prior work suggesting
a role of SLC15A4 in NOD-dependent
signaling (Lee et al., 2009), ensure that
research into SLC15A3 and SLC15A4
biology will continue to drive the field for
some time.
A final intriguing observation made from
this study provides a link to the work of
Kaparakis-Liaskos. Both groups sought
to identify the subcellular site of NOD-
dependent signal transduction, and both
arrived at endosomal membranes as the
likely site of these important events. Using
bacterial outermembrane vesicles (OMVs)
as a natural source ofNOD ligands (Kapar-
akis et al., 2010), Kaparakis-Liaskos
and colleagues found that OMV-contain-
ing endosomes recruit NOD1 and the014 Elsevier Inc.downstream kinase RIPK2.
This recruitment correlated
withNOD-dependent cytokine
secretion and the induction
of autophagy. Evidence was
also presented to indicate
direct interactions between
NOD1 and bacterial OMVs.
These experiments were im-
portant as theyprovide thefirst
direct evidence of an interac-
tion between NOD1 and a
natural (not chemical) ligand.
Similarly, the Mellman group
used MDP-containing beads
(orSalmonella) to demonstrate
the recruitment of NOD1,
NOD2, and RIPK2 to endo-
somal membranes. Interest-
ingly, phagosomes containing
NOD ligands also displayed
SLC15A3, which further sup-
ports its role in transporting
microbial products.
The fact that NOD1 and
NOD2 signaling proceeds
from endosomal membranes
is consistent with prior workindicating that these proteins are not
simply cytosolic receptors that diffuse
through the cell in search of their ligands
(Barnich et al., 2005; Travassos et al.,
2010). Rather, ample evidence now sup-
ports the idea that NLRs (at least in the
case of NOD1 and NOD2) are peripheral
membrane proteins that survey one or
more organelles for bacterial cell wall
components. A notable distinction be-
tween these current works and the earlier
studies is the prior assignment of NOD1
and NOD2 as proteins localized to the
cell surface. Indeed, early studies from
Podolsky and colleagues identified
NOD2 at the surface of epithelia and
found a NOD2 variant that is functionally
implicated in the pathology of Crohn’s
disease to be cytosolic (Barnich et al.,
2005). Mellman’s work also examined
the localization of this Crohn’s variant of
NOD2 and found it to be mislocalized to
the cytosol. A possible explanation for
the differences in NOD localization ob-
served by different groups is that NOD
proteins may have the ability to bind
different organelles. We propose that
NOD proteins may first be recruited from
the cytosol to the cell surface during the
process of endocytosis or phagocytosis
(Figure 1). This recruited pool of NODs
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nascent vesicles and await the release of
bacterial cell wall fragments by a process
facilitated by SLC15A3 (Figure 1). If
correct, then understanding the mecha-
nisms of NOD recruitment to the cell
surface or endosomes may be an inter-
connected question, and NODs may
have a single domain within their
sequence that permits interactions with
proteins (or lipids) in both locations of
the cell. In this regard, it is worth noting
recent work demonstrating that the TLR
adaptor protein TIRAP functions in this
way (Bonham et al., 2014), interacting
with lipids at the cell surface and endo-
somes to facilitate the detection of active
receptors. Once detection of active TLRs
is achieved, TIRAP recruits its down-
stream partner MyD88 to initiate signal
transduction (Bonham et al., 2014). It will
be important to understand when NODs
are first recruited to membranes. Are
these proteins targeted to membranes
immediately after they are synthesized
(like TIRAP), or are they recruited by asignal-dependent process (like MyD88)?
Follow-up research into this new exciting
area of NOD cell biology will surely pro-
vide answers to these questions and
may help explain the operation of the
other receptor families of the innate
immune system.
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